Gene Query: ATP13A3

Dataset Description Geneva Score
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 64.59
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 57.98
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 46.45
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 45.4
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 43.9
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 40.59
RNAseq Analysis in glioblastoma cells treated with Mepazine 40.3
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 38.75
Active translatome profiling with RiboLace in MCF7 cells 37.76
ZIKV infection of monocytes activates inflammasome pathways 36.11
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 33.84
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 33.77
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 33.09
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 32.41
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 31.85
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 31.85
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 31.05
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 30.88
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 30.08
Differetially expressed genes after hTR overexpression in U2OS cells 29.68
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 29.56
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 29.56
High-throughput sequencing of PROMPT-enriched samples. 29.0
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 27.96
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 27.94
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 27.68
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 27.36
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 27.31
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 27.18
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 26.94
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 26.78
RNA-seq of shEZH2 cells 25.81
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 25.51
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 25.18
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 25.16
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 24.89
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 24.58
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 24.24
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 24.08
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 24.08
RNA sequencing of matched nephrectomy samples [RNA-seq] 23.96
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 23.96
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 23.86
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 23.84
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 23.21
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 23.1
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 22.67
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 22.67
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 22.58
Ribosomal footprinting of CN34-Parental and CN34-LM1a 22.49
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 22.36
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 22.33
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 22.33
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 22.06
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 22.02
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 21.9
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 21.67
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 21.64
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 21.53
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 21.49
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 21.4
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 21.22
Regulation of highly expressed hCINAP on translatome 20.91
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 20.87
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 20.87
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 20.86
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 20.84
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 20.78
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 20.76
RIG-I and MDA5 fRIP during KSHV lytic reactivation 20.59
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 20.5
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 20.39
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 20.33
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 20.29
Ribosomal footprinting of MDA-Parental and MDA-LM2 20.1
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 20.08
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 19.93
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 19.93
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 19.9
Human cell line and subcutaneous tumor 19.72
Survival of pancreatic cancer cells lacking KRAS function 19.7
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 19.63
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 19.63
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 19.54
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 19.3
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 19.2
Genes significantly down or Up-regulated upon RNF219 knockdown 19.16
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 19.02
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 19.02
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 19.02
Intron retention induced by microsatellite expansions as a disease biomarker. 18.93
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 18.76
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 18.76
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 18.74
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 18.68
Anti-inflammatory effect of indoleacrylic acid (IA) 18.43
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 18.43
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 18.43
The transcriptome effect of overexpressing EZH2 in MCF7 18.34
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 18.3
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 18.09
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 17.97
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 17.83
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 17.73
Role for citron kinase in prostate cancer growth 17.72
Tracing Enhancer Networks using Epigenetic Traits (TENET) 17.58
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 17.53
hTERT promotes cell adhesion and migration independent of telomerase activity 17.5
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 17.48
UBC9 knockdown in bladder cancer T24 cell lines 17.2
Expression data from miR340 overexpressing human A549 cells 17.19
Global response to chemotherapy-induced apoptosis 17.15
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 16.88
3’ Uridylation Expands miRNA Target Repertoire 16.86
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 16.8
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 16.79
Recovery and analysis of nascent RNA 16.79
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 16.58
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 16.35
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 16.29
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 16.03
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 15.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 15.88
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 15.88
Systematic discovery of endogenous human ribonucleoprotein complexes 15.53
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 15.42
BAF controls genome accessibility 15.3
HNF1A deficiency impairs β-cell fate, granule maturation and function 15.19
Fibroblasts in cholesteatoma activate osteoclasts. 14.99
Role of XRN2 ribonucleolytic activity in RNA metabolism 14.83
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 14.82
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 14.78
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 14.65
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 14.64
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 14.64
A Unique Epigenomic Landscape Defines Human Erythropoiesis 14.49
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 14.49
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 14.36
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 14.3
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 14.07
Transcriptomic profiling of human peripheral blood-derived mast cells 14.07
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 14.07
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 14.03
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 13.97
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 13.97
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 13.92
MYC dependent mRNA translation shapes gene expression and cell biology 13.83
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 13.81
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 13.76
RNA-seq analyisis of PUM2 knockout cells 13.76
RNA-Seq analysis of breast cancer cells after shikonin treatment 13.65
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 13.52
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.3
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.22
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 13.19
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 13.14
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 13.12
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.12
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.12
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 13.11
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 13.11
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 13.1
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 13.1
Novel Targeting of Transcription and Metabolism in Glioblastoma 13.1
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 13.01
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 12.94
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 12.94
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 12.84
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 12.8
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 12.8
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 12.76
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 12.76
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 12.76
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 12.74
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 12.74
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 12.67
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 12.67
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 12.66
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 12.66
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 12.64
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 12.58
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.51
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 12.5
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 12.48
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 12.41
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 12.38
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 12.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 12.31
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 12.19
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 12.17
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.12
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 12.07
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 12.05
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 11.93
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 11.83
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 11.73
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 11.71
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 11.69
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.66
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 11.66
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 11.65
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 11.65
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 11.59
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 11.56
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 11.54
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 11.54
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.53
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.53
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 11.53
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 11.5
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 11.49
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 11.4
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 11.4
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 11.29
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 11.29
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 11.14
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 11.14
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 11.12
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 11.08
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 11.02
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 11.01
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 10.96
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 10.95
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.8
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 10.63
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 10.61
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 10.54
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 10.53
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.47
Small-molecule targeting of brachyury transcription factor addiction in chordoma 10.44
Macrophage Ad5f35 M2 Challenge 10.34
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 10.28
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 10.23
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 10.2
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 10.15
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 10.09
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 10.08
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 9.95
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 9.93
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 9.93
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 9.85
Induced DNA demethylation, genome instability and transcription 9.85
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 9.82
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 9.81
Transcriptome of activated human and mouse MAIT cells 9.71
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 9.65
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 9.65
Role of cervicovaginal microbiota in genital inflammation 9.64
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 9.58
The Genomic Landscape of Atypical Fibroxanthoma 9.54
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 9.53
miR941 overexpression experiment 9.46
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 9.46
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 9.4
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 9.35
RNA-seq analysis of BAP1-depleted uveal melanoma cells 9.32
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 9.28
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 9.28
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 9.21
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 9.02
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 9.02
Regulatory network controlling tumor-promoting inflammation in human cancers 8.96
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 8.96
BCL11B 8.95
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.76
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 8.69
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 8.52
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 8.51
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 8.48
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 8.29
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 8.28
A transcriptome dataset revealing the molecular features of breast cancer stem cells 8.25
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 8.22
Capturing the Interactome of Newly Transcribed RNA (RICK) 8.15
Capturing the Interactome of Newly Transcribed RNA 8.15
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 8.15
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 8.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 8.05
X-Ray induced DNA-Hydroxymethylation changes 8.05
The DPYSL2 gene connects mTOR and schizophrenia 7.96
Transcriptomes of human monocytes after ex vivo exposure to uric acid 7.92
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 7.89
Total RNA sequencing of WT intestinal orgaonids. 7.88
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.82
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.64
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 7.62
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 7.62
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.56
N6-methyladenine DNA Modification in Glioblastoma 7.56
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 7.3
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 7.22
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 7.21
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 7.21
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 7.19
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.19
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.19
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 7.14
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.01
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 6.99
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.92
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 6.88
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.81
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 6.81
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 6.8
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 6.77
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.76
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 6.74
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.72
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.71
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 6.64
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.53
The cohesin release factor WAPL restricts chromatin loop extension. 6.53
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 6.52
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.48
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 6.44
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 6.36
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 6.27
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 6.26
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 6.24
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 6.23
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 6.23
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 6.23
Characterization of the Merkel cell carcinoma miRNome 6.23
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 6.13
RNA-Seq of PRMT1 overexpression ECA109 cells 6.13
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.1
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 6.08
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 6.08
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 6.01
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 6.0
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 5.95
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 5.94
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.93
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.8
SLAM-seq for K562 endogenous mRNA decay 5.77
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 5.76
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 5.75
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.7
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 5.65
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 5.62
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 5.6
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 5.55
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 5.48
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 5.37
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 5.23
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.17
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 5.1
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 5.02
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 4.98
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.92
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 4.81
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.79
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.77
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.72
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.62
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 4.56
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.44
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 4.35
Copper Regulation of HIF-1 Transcription Activity 4.35
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.35
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.33
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.23
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 4.23
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.21
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.13
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 4.12
Aneuploidy triggers an immune response 3.98
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.97
Interaction between mitoNEET and NAF-1 in cancer cells 3.94
Human Treg IFNg/IL-10 subpopulations 3.84
Interphase condensins regulate ligand-depedent enhancer activation 3.75
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 3.75
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.7
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.69
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.68
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.68
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.68
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 3.6
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.58
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.51
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.49
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 3.48
The circadian transcriptional landscape in primary human mammary epithelial cells 3.48
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.47
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.44
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 3.41
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 3.41
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.39
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.31
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.31
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.31
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.31
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.29
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.25
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.25
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.24
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.23
RNA seq_PDX2_SHP099 3.19
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 3.18
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 3.12
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.11
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.11
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.09
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.03
Exogenous rescue of KLHL9 in SF210 cell line 2.98
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.97
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.95
mRNA-Seq profiling of human developing kidney 2.81
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.71
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.7
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.67
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 2.63
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.61
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.54
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.53
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 2.32
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.2
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.19
RNAseq of cell lines with knocked in ESR1 mutations 2.17
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.17
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.17
Aortic Valve Tissue: Stenosis vs. Sclerosis 2.16
RNA expression profiles comparing primary and omental ovarian carcinoma samples 2.1
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.09
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 2.09
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 2.09
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.92
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.89
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.86
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.85
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.82
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.8
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.74
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.72
Nonpregnant and term pregnant human myometrial tissues 1.71
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 1.71
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.65
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.64
Transcriptomes in healthy and CHB fetal hearts 1.58
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.53
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.53
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.52
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.52
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.51
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 1.51
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.5
Impact on erythroid progenitor type on erythroid differntiation 1.49
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.49
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.43
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.41
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.35
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.29
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.29
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.16
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.15
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.13
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.09
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.09
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.07
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.98
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.89
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.88
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.86
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.85
The role of the Calcium-Sensing receptor in colorectal cancer 0.8
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.75
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.75
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.73
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.71
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.71
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.7
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.67
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.66
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.63
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 0.61
Dilated cardiomyopathy vs Myocarditis 0.6
Generation and functional characterization of MDSC-like cells 0.56
Modulation of nonsense-mediated decay by rapamycin 0.51
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.51
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.51
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.46
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 0.37
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 0.37
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.33
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.29
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.26
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.24
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.23
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.23
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.22
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.2
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.19
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.15
Gene expression profile of human placenta from T. Cruzi infected mothers 0.15
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.09
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation